Chi Sheng Pharma & Biotech Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chi Sheng Pharma & Biotech Co Ltd

Watchlist Manager

Watchlist

Price: 29.95 TWD -0.33% Market Closed

Market Cap: NT$1.8B

C	Chi Sheng Pharma & Biotech Co Ltd TPEX:4111	TW
M	MacroWell OMG Digital Entertainment Co Ltd TPEX:3687	TW
	Al Maather REIT Fund SAU:4334	SA
	Gabather AB F:5J2	SE

Profitability Summary

Chi Sheng Pharma & Biotech Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

40%

Sustainable 3Y Average Gross Margin

35%

Gross Margin is Increasing

35% > 40%

Healthy Operating Margin

15%

Low 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 15%

Healthy Net Margin

13%

Low 3Y Average Net Margin

10%

Net Margin is Increasing

13% > 13%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.